September - 2016

top of page

Sage Group News

Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products

Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products

Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products

ABOUT APR Applied Pharma Research s.a. (www.apr.ch; “APR” or the “Company”) is a profitable, well-financed, privately held, Swiss...

bottom of page